PubMed

The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.

Douketis JD, Gu CS, Schulman S, Ghirarduzzi A, Pengo V, Prandoni P.

Ann Intern Med. 2007 Dec 4;147(11):766-74.PMID: 18056660 [PubMed - indexed for MEDLINE]Related articlesFree article

The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A.

Haematologica. 2007 Feb;92(2):199-205.PMID: 17296569 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk of fatal pulmonary embolism in patients with treated venous thromboembolism.

Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS.

JAMA. 1998 Feb 11;279(6):458-62.PMID: 9466640 [PubMed - indexed for MEDLINE]Related articlesFree article

Short-term clinical outcome after acute symptomatic pulmonary embolism.

Conget F, Otero R, Jiménez D, Martí D, Escobar C, Rodríguez C, Uresandi F, Cabezudo MA, Nauffal D, Oribe M, Yusen R.

Thromb Haemost. 2008 Nov;100(5):937-42.PMID: 18989541 [PubMed - indexed for MEDLINE]Related articles

Extended oral anticoagulant therapy after a first episode of pulmonary embolism.

Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M, Imberti D, Poggio R, Ageno W, Pogliani E, Porro F, Zonzin P; Warfarin Optimal Duration Italian Trial Investigators.

Ann Intern Med. 2003 Jul 1;139(1):19-25.PMID: 12834314 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy.

Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS.

Arch Intern Med. 2000 Dec 11-25;160(22):3431-6.PMID: 11112236 [PubMed - indexed for MEDLINE]Related articlesFree article

The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.

Jiménez D, Díaz G, Marín E, Vidal R, Sueiro A, Yusen RD.

Thromb Haemost. 2006 Mar;95(3):562-6.PMID: 16525588 [PubMed - indexed for MEDLINE]Related articles

The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study.

Nijkeuter M, Söhne M, Tick LW, Kamphuisen PW, Kramer MH, Laterveer L, van Houten AA, Kruip MJ, Leebeek FW, Büller HR, Huisman MV; Christopher Study Investigators.

Chest. 2007 Feb;131(2):517-23.PMID: 17296656 [PubMed - indexed for MEDLINE]Related articlesFree article

[Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial]

Couturaud F, Pernod G, Pison C, Mismetti P, Sanchez O, Meyer G, Parent F, Girard P, Simonneau G, Drouet L, Gueret P, Jego P, Delaval P, Duhamel E, Gruel Y, Delahousse B, Regina S, Pottier P, Connaud J, Lecomte F, Provost K, Vilmans N, Gosset X, Bura-Rivière A, Meach G, Lacut K, Bosson JL, Guillot K, Mottier D, Leroyer C.

Rev Mal Respir. 2008 Sep;25(7):885-93. French. PMID: 18946418 [PubMed - indexed for MEDLINE]Related articles

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Epub 2007 Oct 1. Review.PMID: 17906973 [PubMed - indexed for MEDLINE]Related articles

Duration of anticoagulation therapy for venous thromboembolism.

Bounameaux H, Perrier A.

Hematology Am Soc Hematol Educ Program. 2008:252-8.PMID: 19074092 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.

Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I, Nony P, Sanson C, Boissel JP; Investigators of the "Durée Optimale du Traitement AntiVitamines K" (DOTAVK) Study.

Circulation. 2001 May 22;103(20):2453-60.PMID: 11369685 [PubMed - indexed for MEDLINE]Related articlesFree article

Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.

Willey VJ, Bullano MF, Hauch O, Reynolds M, Wygant G, Hoffman L, Mayzell G, Spyropoulos AC.

Clin Ther. 2004 Jul;26(7):1149-59.PMID: 15336480 [PubMed - indexed for MEDLINE]Related articles

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Pinede L, Ninet J, Duhaut P et al for the Investigators of the 'Durée Optimale du Traitement Antivitamines K' (DOTAVK) study. Circulation 2001; 103: 2453-60.

Anand SS.

Vasc Med. 2001 Nov;6(4):269-70.PMID: 11958396 [PubMed - indexed for MEDLINE]Related articles

Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.

Bullano MF, Willey V, Hauch O, Wygant G, Spyropoulos AC, Hoffman L.

J Manag Care Pharm. 2005 Oct;11(8):663-73.PMID: 16194130 [PubMed - indexed for MEDLINE]Related articlesFree article

Death due to recurrent thromboembolism among younger healthier individuals hospitalized for idiopathic pulmonary embolism.

White RH, Zhou H, Murin S.

Thromb Haemost. 2008 Apr;99(4):683-90.PMID: 18392326 [PubMed - indexed for MEDLINE]Related articles

Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors.

Hansson PO, Sörbo J, Eriksson H.

Arch Intern Med. 2000 Mar 27;160(6):769-74.PMID: 10737276 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.

Nieto JA, Camara T, Gonzalez-Higueras E, Ruiz-Gimenez N, Guijarro R, Marchena PJ, Monreal M; RIETE Investigators.

Thromb Haemost. 2008 Nov;100(5):789-96.PMID: 18989522 [PubMed - indexed for MEDLINE]Related articles

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy.

Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, Solymoss S, Crowther M, Perrier A, White R, Vickars L, Ramsay T, Betancourt MT, Kovacs MJ.

CMAJ. 2008 Aug 26;179(5):417-26.PMID: 18725614 [PubMed - indexed for MEDLINE]Related articlesFree article

Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.

Trujillo-Santos J, Nieto JA, Tiberio G, Piccioli A, Di Micco P, Prandoni P, Monreal M; RIETE Registry.

Thromb Haemost. 2008 Sep;100(3):435-9.PMID: 18766259 [PubMed - indexed for MEDLINE]Related articles